Based on this, ZEB1 suppression by miR-200 expression or histone deacetylase inhibitor (mocetinostat) re-sensitized mesenchymal cells to MEK inhibition and markedly reduced in vivo tumor growth. Here, MAP2K7 is linked to neoplasm.